Protein drives inflammation in rheumatoid arthritis patients
|Protein drives inflammation in rheumatoid arthritis patients||Darrell Miller||11/28/16|
November 28, 2016 08:59 AM
Author: Darrell Miller (email@example.com)
Subject: Protein drives inflammation in rheumatoid arthritis patients
A recent study found that patients suffering from rheumatoid arthritis with higher levels of the protein type 1 interferon beta do not respond as well to treatment with tumor necrosis factor inhibitors. This research will prove to be invaluable in the future in order to personalize treatment plans for people with rheumatoid arthritis.
- It comes down to proteins: specifically, a protein in the body that drives inflammation in the disease, the research found.
- The discovery is an important step toward better personalizing rheumatoid arthritis treatment, helping to avoid trial and error when prescribing medications.
- The discovery paves the way for a more personalized approach to treatment in rheumatoid arthritis based on the biology of a particular patient’s disease.
"A recent research has found that a certain protein in the body causes inflammation in rheumatoid arthritis patients which in turn will help avoid trial and error when prescribing medications."